Literature DB >> 24918518

Lack of association between APOE gene polymorphisms and amyotrophic lateral sclerosis: a comprehensive meta-analysis.

Flora Govone1, Alessandro Vacca, Elisa Rubino, Annalisa Gai, Silvia Boschi, Salvatore Gentile, Laura Orsi, Lorenzo Pinessi, Innocenzo Rainero.   

Abstract

Several studies have evaluated the association between APOE gene polymorphisms and the risk for amyotrophic lateral sclerosis (ALS), with inconclusive results. The aim of our study was to further define the risk associated with carriage of the APOE alleles and development and clinical characteristics of ALS. We performed a comprehensive meta-analysis of all existing studies investigating the association between the APOE gene and ALS published up to September 2013, comprising a total of 4249 ALS patients and 10,397 controls. Pooled odds ratios (OR) were estimated using the random effect (RE) model. Results showed that the carriage of different APOE alleles had no effect on disease risk. In particular, the ϵ4 allele was not associated with a significantly increased disease risk (ϵ4 carriers vs. non-ϵ4 carriers: RE OR 1.18; 95% CI 0.91-1.53). In conclusion, our study suggests that the APOE gene does not have a significant effect in ALS aetiopathogenesis.

Entities:  

Keywords:  APOE; Amyotrophic lateral sclerosis; gene; meta-analysis; polymorphism

Mesh:

Substances:

Year:  2014        PMID: 24918518     DOI: 10.3109/21678421.2014.918149

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  6 in total

Review 1.  Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.

Authors:  Tien-Phat V Huynh; Albert A Davis; Jason D Ulrich; David M Holtzman
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

2.  To Dement or Not to Dement, That Is the Question.

Authors:  Bryan J Traynor; Yevgeniya A Abramzon
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 3.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

Review 4.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

5.  Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Andreas Giannisis; Asma Al-Grety; Henrik Carlsson; Kalicharan Patra; Daniel Twohig; Sigrid Botne Sando; Camilla Lauridsen; Guro Berge; Gøril Rolfseng Grøntvedt; Geir Bråthen; Linda R White; Kim Kultima; Henrietta M Nielsen
Journal:  Alzheimers Res Ther       Date:  2022-08-24       Impact factor: 8.823

Review 6.  APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.

Authors:  Zonghua Li; Francis Shue; Na Zhao; Mitsuru Shinohara; Guojun Bu
Journal:  Mol Neurodegener       Date:  2020-11-04       Impact factor: 18.879

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.